source
- Two more biotechs, Marea and North Immunology, do reverse mergersThe reverse merger party is still buzzing. This time, it's a cardio and endocrine startup with two drugs in Phase 2 and a biotech working on a long-acting immunology and inflammation (I&I) drug. Mi…Endpoints · 1mo ago↗ source
- Novartis drops $125M for Sironax’s tech to cross blood-brain barrierNovartis stands alongside Big Pharma peers that have similarly invested in technologies to penetrate the blood-brain barrier, including GSK, Roche and Eli Lilly.BioSpace · 1mo ago↗ source
- Roche turns to Dualitas to find new bispecific approaches for immunologyRoche is turning up the heat on its hunt for next-generation bispecific antibodies in a deal that will involve screening 300,000 new combinations for inflammatory and immunology conditions. The Swi…